Skip to main content
Fig. 2 | Thrombosis Journal

Fig. 2

From: Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis

Fig. 2

One-way sensitivity analyses (Tornado diagram) over 6-month (left) and 5-year time horizon (right). In the graph, a horizontal bar is generated for each variable being analyzed. Incremental cost is displayed on the horizontal axis, so each bar represents the selected node’s range of incremental values generated by varying the related variable. A wide bar indicates that the associated variable has a large potential effect on the expected value of the model. This variable with the widest bar (potentially the most critical uncertainty) is plotted on the top. DOACs, direct oral anticoagulants; LMWHs, low molecular weight heparins. CRNMB: clinically relevant non-major bleeding; offAC, anticoagulant treatment discontinuation; ICER, incremental cost-effectiveness ratio; QALYs: quality adjusted life-years (QALYs)

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us